BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15975569)

  • 21. Cooperative regulation of anxiety and panic-related defensive behaviors in the rat periaqueductal grey matter by 5-HT1A and μ-receptors.
    Roncon CM; Biesdorf C; Coimbra NC; Audi EA; Zangrossi H; Graeff FG
    J Psychopharmacol; 2013 Dec; 27(12):1141-8. PubMed ID: 23598399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray.
    Yamashita PS; de Bortoli VC; Zangrossi H
    Neuropharmacology; 2011; 60(2-3):216-22. PubMed ID: 20850460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired fear inhibitory properties of GABAA and μ opioid receptors of the dorsal periaqueductal grey in alcohol-withdrawn rats.
    Silva LBC; Nobre MJ
    Acta Neurobiol Exp (Wars); 2014; 74(1):54-66. PubMed ID: 24718044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABAA receptors in the midbrain central grey mediate the antiaversive action of GABA.
    Audi EA; Graeff FG
    Eur J Pharmacol; 1987 Mar; 135(2):225-9. PubMed ID: 3034627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the brain aversive system by GABAergic and serotonergic mechanisms.
    Graeff FG; Brandão ML; Audi EA; Schütz MT
    Behav Brain Res; 1986 Jul; 21(1):65-72. PubMed ID: 3017372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
    Strauss CV; Vicente MA; Zangrossi H
    Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic effect of midazolam microinjected into the dorsal periaqueductal grey area of rats.
    Russo AS; Guimarães FS; De Aguiar JC; Graeff FG
    Braz J Med Biol Res; 1991; 24(6):607-9. PubMed ID: 1823278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety.
    Dos Santos L; de Andrade TG; Zangrossi H
    Psychopharmacology (Berl); 2005 Jun; 179(4):733-41. PubMed ID: 15619105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
    Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
    Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O; Spiacci A; Zangrossi H
    Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal gray matter μ-opioid receptors.
    Roncon CM; Almada RC; Maraschin JC; Audi EA; Zangrossi H; Graeff FG; Coimbra NC
    Neuropharmacology; 2015 Dec; 99():620-6. PubMed ID: 26320545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prior electrical stimulation of dorsal periaqueductal grey matter or deep layers of the superior colliculus sensitizes rats to anxiety-like behaviors in the elevated T-maze test.
    de Almeida LP; Ramos PL; Pandossio JE; Landeira-Fernandez J; Zangrossi H; Nogueira RL
    Behav Brain Res; 2006 Jun; 170(2):175-81. PubMed ID: 16569447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors.
    Soares Vde P; Campos AC; Bortoli VC; Zangrossi H; Guimarães FS; Zuardi AW
    Behav Brain Res; 2010 Dec; 213(2):225-9. PubMed ID: 20457188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal gray.
    De Oliveira Sergio T; Frias AT; Vilela-Costa HH; De Oliveira DC; Zuardi AW; Zangrossi H
    J Psychopharmacol; 2020 Apr; 34(4):383-390. PubMed ID: 32108540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opiorphin causes a panicolytic-like effect in rat panic models mediated by μ-opioid receptors in the dorsal periaqueductal gray.
    Maraschin JC; Rangel MP; Bonfim AJ; Kitayama M; Graeff FG; Zangrossi H; Audi EA
    Neuropharmacology; 2016 Feb; 101():264-70. PubMed ID: 26363194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats.
    Castilho VM; Macedo CE; Brandão ML
    Psychopharmacology (Berl); 2002 Dec; 165(1):77-85. PubMed ID: 12474121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of neurokinin-1 and 3-receptor antagonists on the defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray.
    Broiz AC; Bassi GS; De Souza Silva MA; Brandão ML
    Neuroscience; 2012 Jan; 201():134-45. PubMed ID: 22123168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The benzodiazepine midazolam acts on the expression of the defensive behavior, but not on the processing of aversive information, produced by exposure to the elevated plus maze and electrical stimulations applied to the inferior colliculus of rats.
    Saito VM; Brandão ML
    Neuropharmacology; 2015 Jan; 88():180-6. PubMed ID: 25107589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
    Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.